BioPharm International-01-01-2018

BioPharm International

Surveys Redefine “Ready”

January 01, 2018

Features

31

1

Pharmaceutical companies and contract manufacturing organizations report lack of readiness for the November 2018 US Drug Supply Chain Security Act serialization deadline.

Moving Toward Open Standard Specifications for Serialization Integration

January 01, 2018

Features

31

1

A review of 2017 advancements from the Open-SCS working group with Charlie Gifford, group technical director.

Milestones Mark Progress and Challenges

January 01, 2018

From the Editor

31

1

BioPharm International will mark 30 years of biopharma industry progress and challenges in 2018.

Drug Pricing and Quality Are Top Issues for 2018

January 01, 2018

Regulatory Beat

31

1

Policy makers look to boost generic drugs, curb opioid abuse, and maintain incentives for innovation.

What to Watch for in 2018

January 01, 2018

Perspectives on Outsourcing

31

1

The industry will see an impact from financing, M&As, advanced therapies, generic drugs, and the retail market in 2018.

Meeting Data Integrity Requirements

January 01, 2018

Ask the Expert

31

1

Enterprise-wide processes, procedures, and systems are the keys to data integrity and peace of mind, according to Siegfried Schmitt, PhD, principal consultant at PAREXEL.

BioPharm International, January 2018 Issue (PDF)

January 01, 2018

Issue PDF

31

1

Click the title above to open the BioPharm International January 2018 issue in an interactive PDF format.